Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein–Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation

Quorum sensing (QS) is a cell-to-cell communication mechanism that regulates bacterial pathogenicity, biofilm formation, and antibiotic sensitivity. Among the identified quorum sensing, AI-2 QS exists in both Gram-negative and Gram-positive bacteria and is responsible for interspecies communication....

Full description

Bibliographic Details
Main Authors: Yijie Xu, Chunlan Zeng, Huiqi Wen, Qianqian Shi, Xu Zhao, Qingbin Meng, Xingzhou Li, Junhai Xiao
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/16/5/737
_version_ 1797598736687300608
author Yijie Xu
Chunlan Zeng
Huiqi Wen
Qianqian Shi
Xu Zhao
Qingbin Meng
Xingzhou Li
Junhai Xiao
author_facet Yijie Xu
Chunlan Zeng
Huiqi Wen
Qianqian Shi
Xu Zhao
Qingbin Meng
Xingzhou Li
Junhai Xiao
author_sort Yijie Xu
collection DOAJ
description Quorum sensing (QS) is a cell-to-cell communication mechanism that regulates bacterial pathogenicity, biofilm formation, and antibiotic sensitivity. Among the identified quorum sensing, AI-2 QS exists in both Gram-negative and Gram-positive bacteria and is responsible for interspecies communication. Recent studies have highlighted the connection between the phosphotransferase system (PTS) and AI-2 QS, with this link being associated with protein-protein interaction (PPI) between HPr and LsrK. Here, we first discovered several AI-2 QSIs targeting the LsrK/HPr PPI site through molecular dynamics (MD) simulation, virtual screening, and bioassay evaluation. Of the 62 compounds purchased, eight compounds demonstrated significant inhibition in LsrK-based assays and AI-2 QS interference assays. Surface plasmon resonance (SPR) analysis confirmed that the hit compound 4171-0375 specifically bound to the LsrK-N protein (HPr binding domain, KD = 2.51 × 10<sup>−5</sup> M), and therefore the LsrK/HPr PPI site. The structure-activity relationships (SARs) emphasized the importance of hydrophobic interactions with the hydrophobic pocket and hydrogen bonds or salt bridges with key residues of LsrK for LsrK/HPr PPI inhibitors. These new AI-2 QSIs, especially 4171-0375, exhibited novel structures, significant LsrK inhibition, and were suitable for structural modification to search for more effective AI-2 QSIs.
first_indexed 2024-03-11T03:25:55Z
format Article
id doaj.art-e5f3a2f0ae4a48e6b974fce27ba5882d
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-11T03:25:55Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-e5f3a2f0ae4a48e6b974fce27ba5882d2023-11-18T02:49:12ZengMDPI AGPharmaceuticals1424-82472023-05-0116573710.3390/ph16050737Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein–Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay EvaluationYijie Xu0Chunlan Zeng1Huiqi Wen2Qianqian Shi3Xu Zhao4Qingbin Meng5Xingzhou Li6Junhai Xiao7National Engineering Research Center for Strategic Drugs, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaState Key Laboratory of Pathogen and Biosecurity, Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, ChinaNational Engineering Research Center for Strategic Drugs, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaDepartment of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, ChinaState Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaNational Engineering Research Center for Strategic Drugs, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaNational Engineering Research Center for Strategic Drugs, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, ChinaQuorum sensing (QS) is a cell-to-cell communication mechanism that regulates bacterial pathogenicity, biofilm formation, and antibiotic sensitivity. Among the identified quorum sensing, AI-2 QS exists in both Gram-negative and Gram-positive bacteria and is responsible for interspecies communication. Recent studies have highlighted the connection between the phosphotransferase system (PTS) and AI-2 QS, with this link being associated with protein-protein interaction (PPI) between HPr and LsrK. Here, we first discovered several AI-2 QSIs targeting the LsrK/HPr PPI site through molecular dynamics (MD) simulation, virtual screening, and bioassay evaluation. Of the 62 compounds purchased, eight compounds demonstrated significant inhibition in LsrK-based assays and AI-2 QS interference assays. Surface plasmon resonance (SPR) analysis confirmed that the hit compound 4171-0375 specifically bound to the LsrK-N protein (HPr binding domain, KD = 2.51 × 10<sup>−5</sup> M), and therefore the LsrK/HPr PPI site. The structure-activity relationships (SARs) emphasized the importance of hydrophobic interactions with the hydrophobic pocket and hydrogen bonds or salt bridges with key residues of LsrK for LsrK/HPr PPI inhibitors. These new AI-2 QSIs, especially 4171-0375, exhibited novel structures, significant LsrK inhibition, and were suitable for structural modification to search for more effective AI-2 QSIs.https://www.mdpi.com/1424-8247/16/5/737AI-2quorum sensingantibacterial agentsLsrKvirtual screeningmolecular dynamics
spellingShingle Yijie Xu
Chunlan Zeng
Huiqi Wen
Qianqian Shi
Xu Zhao
Qingbin Meng
Xingzhou Li
Junhai Xiao
Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein–Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation
Pharmaceuticals
AI-2
quorum sensing
antibacterial agents
LsrK
virtual screening
molecular dynamics
title Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein–Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation
title_full Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein–Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation
title_fullStr Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein–Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation
title_full_unstemmed Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein–Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation
title_short Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein–Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation
title_sort discovery of ai 2 quorum sensing inhibitors targeting the lsrk hpr protein protein interaction site by molecular dynamics simulation virtual screening and bioassay evaluation
topic AI-2
quorum sensing
antibacterial agents
LsrK
virtual screening
molecular dynamics
url https://www.mdpi.com/1424-8247/16/5/737
work_keys_str_mv AT yijiexu discoveryofai2quorumsensinginhibitorstargetingthelsrkhprproteinproteininteractionsitebymoleculardynamicssimulationvirtualscreeningandbioassayevaluation
AT chunlanzeng discoveryofai2quorumsensinginhibitorstargetingthelsrkhprproteinproteininteractionsitebymoleculardynamicssimulationvirtualscreeningandbioassayevaluation
AT huiqiwen discoveryofai2quorumsensinginhibitorstargetingthelsrkhprproteinproteininteractionsitebymoleculardynamicssimulationvirtualscreeningandbioassayevaluation
AT qianqianshi discoveryofai2quorumsensinginhibitorstargetingthelsrkhprproteinproteininteractionsitebymoleculardynamicssimulationvirtualscreeningandbioassayevaluation
AT xuzhao discoveryofai2quorumsensinginhibitorstargetingthelsrkhprproteinproteininteractionsitebymoleculardynamicssimulationvirtualscreeningandbioassayevaluation
AT qingbinmeng discoveryofai2quorumsensinginhibitorstargetingthelsrkhprproteinproteininteractionsitebymoleculardynamicssimulationvirtualscreeningandbioassayevaluation
AT xingzhouli discoveryofai2quorumsensinginhibitorstargetingthelsrkhprproteinproteininteractionsitebymoleculardynamicssimulationvirtualscreeningandbioassayevaluation
AT junhaixiao discoveryofai2quorumsensinginhibitorstargetingthelsrkhprproteinproteininteractionsitebymoleculardynamicssimulationvirtualscreeningandbioassayevaluation